FDA OKs New Agent to Block Chemotherapy-Induced Neutropenia

The new colony-stimulating factor from China proved comparable to pegfilgrastim (Neulasta) in clinical testing.

Related Keywords

,Drug Administration ,Evive Biotech ,Neutropenia ,Chemotherapy ,Thrombocytopenia ,Breast Cancer ,Alignant Breast Neoplasm ,Breast ,Cancer ,Alignant Neoplasia ,Arcinoma ,Us Food And Drug Administration ,Nited States Food And Drug Administration ,Fda ,Biologic Therapy ,Adverse Effects ,Side Effects ,Anemia ,Biomedical Technology ,Biotechnology ,Fellowship ,Yellows ,Nausea ,Physician Assistants ,Splenic Rupture ,Ruptured Spleen ,Acute Respirator ,